SCHEMBL4591419

SCHEMBL4591419

Cc1cc(N2C(=O)C3C(C2=O)[C@H]2CC[C@@H]3CC2=O)ccc1F

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
TSHR P16473 5/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALOX15 P16050 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3186387 1.00 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C19NPSR1
SCHEMBL4591420 1.00 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C19NPSR1
SCHEMBL3186377 1.00 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C19NPSR1
SCHEMBL3186370 1.00 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C19NPSR1
SCHEMBL3187185 0.90 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C19NPSR1
SCHEMBL13483390 0.90 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C19NPSR1
SCHEMBL3187179 0.90 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C19NPSR1
SCHEMBL3187169 0.90 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4CYP2C19NPSR1
SCHEMBL3200136 0.88 MEN1 (0.42) ALDH1A1TSHRMEN1KMT2AALOX15
SCHEMBL3191564 0.88 ALDH1A1 (0.57) ALDH1A1TSHRCYP3A4CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379249-A4 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL MYERS SQUIBB CO (US) 2008-01-09 EP claimed
EP-1379249-A1 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION Bristol-Myers Squibb Company (US) 2004-01-14 EP claimed
WO-2002067939-A1 FUSED CYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-06 WO claimed